ARKAF (Arkema) Other Stockholders Equity: $810 Mil (As of Mar. 2026)


ARKAF Arkema SA ARKAF
67 GF Score
Price $68.61
GF Value $82.41
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Arkema Other Stockholders Equity?

Arkema ARKAF 67 Other Stockholders Equity is $810 Mil as of Mar. 2026. GuruFocus rates ARKAF with a GF Score™ of 67/100 and a GF Value™ of $82.41 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Arkema's Other Stockholders Equity for the quarter that ended in Mar. 2026 was $810 Mil.

Arkema's quarterly Other Stockholders Equity declined from Sep. 2025 ($1,081 Mil) to Dec. 2025 ($726 Mil) but then increased from Dec. 2025 ($726 Mil) to Mar. 2026 ($810 Mil).

Arkema's annual Other Stockholders Equity increased from Dec. 2023 ($949 Mil) to Dec. 2024 ($1,097 Mil) but then declined from Dec. 2024 ($1,097 Mil) to Dec. 2025 ($726 Mil).

Arkema Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Arkema's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arkema Other Stockholders Equity Chart

Arkema Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,065.54 1,114.41 948.75 1,097.38 726.00

Arkema Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 932.97 1,088.81 1,080.99 726.00 810.41
ARKAF
67GF Score
Arkema SA ARKAF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arkema Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $810 Mil mean?
Arkema (ARKAF) has a Other Stockholders Equity of $810 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Arkema and its competitors.
Is Arkema's Other Stockholders Equity too high?
Arkema's current Other Stockholders Equity is $810 Mil. Overall, Arkema has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Arkema's Other Stockholders Equity compare to LIN and SHW?
Arkema's Other Stockholders Equity of $810 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Chemicals company?
A good Other Stockholders Equity depends on the Chemicals industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Arkema and its competitors. Arkema's current Other Stockholders Equity is $810 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arkema stock overvalued right now?
Based on GuruFocus' analysis, Arkema (ARKAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $82.41, compared to a current price of $68.61 — trading 16.8% below its estimated fair value. The current Other Stockholders Equity is $810 Mil. Arkema's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Arkema (ARKAF), the current Other Stockholders Equity is $810 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arkema (ARKAF) Overvalued in 2026?

Based on GuruFocus' analysis, Arkema stock appears to be undervalued. The current stock price of $68.61 is trading 16.8% below its estimated GF Value™ of $82.41. GuruFocus considers Arkema to be Modestly Undervalued.

Key valuation signals for ARKAF:

  • Other Stockholders Equity: $810 Mil
  • GF Value™: $82.41 vs. price of $68.61 (16.8% below fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the ARKAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arkema Business Description

Address 51 Esplanade du General de Gaulle, Puteaux - La Defense, Paris, FRA, 92800
Arkema SA operates in the specialty materials industry, offering adhesives, acrylics, technical fluids, chemicals, additives, and other materials that are used in various industries globally. Along with its subsidiaries, it operates in the following segments: Adhesive Solutions, Advanced Materials, Intermediates, and Coating Solutions. Maximum revenue is generated from the Advanced Materials segment, which offers high-performance polymers, like specialty polyamides, PVDF, polyimides, fluorospecialties, and PEKK; and performance additives, covering interface agents, organic peroxides, thiochemicals, and hydrogen peroxide. Geographically, the Group generates maximum revenue from North America, followed by Europe, Asia, and the Rest of the world.
67GF Score

Get the complete analysis for ARKAF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$68.61
Price
$82.41
GF Value